FINANCIAL DUE DILIGENCE
Validate Financial Realities to Protect Your Healthcare Investment
Uncover the true financial realities of your target entity with precise due diligence and Quality of Earnings (QoE) analyses designed to expose hidden vulnerabilities and secure your capital.
Uncovering the Truth Behind the Numbers
Acquiring a healthcare asset based on incomplete financials can introduce undiscovered risk that could jeopardize your deal. Hidden liabilities, unsustainable cost structures, and misstated earnings can quickly turn a promising transaction into a heavy financial burden. You need an unbiased strategic partner to heighten your chances of success before the letter of intent is finalized.
VMG Health’s transaction advisors provide precise financial due diligence to uncover the exact financial health of your target entity. By deeply analyzing historical statements and validating revenue streams, we expose critical vulnerabilities that generalist accounting firms often miss. We translate raw financial data into objective and actionable analysis, empowering your leadership to negotiate from a position of strength and execute transactions with total confidence.
Comprehensive Financial Due Diligence & Quality of Earnings Analysis
Transactions that undergo a healthcare-specific due diligence process can have a significantly higher chance of long-term success.
VMG Health evaluates your target’s underlying run-rate earnings and scrutinizes tax treatments to protect your enterprise value in numerous ways, including:
Focus Area
QoE & Revenue Analysis
We deeply analyze historical statements, evaluate the cash-to-accrual conversion, and validate revenue streams’ sustainability to expose overstated earnings.
Focus Area
Buy-Side & Sell-Side Due Diligence
We provide unbiased financial evaluations tailored to protect buyers from hidden liabilities or help sellers prepare assets for a clean, maximized exit.
Focus Area
Pre-LOI Due Diligence & Adjustments
We assess normalized levels of working capital, identify debt and debt-like items, and calculate pro forma diligence adjustments before you commit to the deal.
Focus Area
Management & Operational Assessments
We scrutinize underlying cost structures to expose critical vulnerabilities and align operations with your long-term growth strategy.
Focus Area
Focus Area
Focus Area
Focus Area
Focus Area
Strategic Due Diligence for Dealmakers
Corporate Development Teams
Chief Financial Officers
Chief Executive Officers
M&A Directors
Boards of Directors
Advancing the Business of Care
30+
Years of Industry Leadership
400+
Healthcare Consultants & Specialists
80K+
Engagements Completed
92%
Client Satisfaction Rating
Financial Due Diligence Experts
Chad Zoretic, CEPA
Managing Director & Partnerships, Mergers & Acquisitions Practice Leader
Lukas Recio, CPA
Managing Director
Joe Scott, CPA
Managing Director
Melissa Hoelting, CPA
Director
Matt Werner, CPA
Director
Uncovering Overstated Revenues in an ASC: A Quality of Earnings Analysis
VMG Health’s Financial Due Diligence team performed a quality of revenue analysis as a component of the QoE, in which the team analyzed and tested the ASC’s accrual basis revenues.
Hear From VMG Health Financial Due Diligence Clients
Definitive Intelligence for M&A Financial Diligence
Access proprietary data, regulatory updates, and strategic frameworks to guide your due diligence processes.
PACE Capitation Meets For-Profit Capital
Since 1971, the Program of All-Inclusive Care for the Elderly (PACE) has operated as one of healthcare’s most effective yet least scaled models. Created to keep nursing home–eligible seniors in their own homes, PACE combines full clinical responsibility with full financial risk. Historically, the…
June 25, 2026
Scaling Cardiology: How Site-of-Care Strategy Is Reshaping M&A
Cardiology transaction activity remains strong, but the underlying investment strategy has evolved significantly over the last several years. Historically, many
Read More
June 10, 2026
When Valuation Formulas & Internally Prepared Valuations Become Compliance Risks
In 2025, civil fraud recoveries reached record levels, primarily driven by healthcare–related qui tam lawsuits. As the Department of Justice
Read More
June 9, 2026
The Next Phase of DSO Consolidation: Opportunity Still Exists, but Expectations Have Changed
The dental service organization (DSO) market remains active, but the environment surrounding transactions has become significantly more disciplined than it
Read More
May 21, 2026
Pharmacy M&A in Transition: Key Trends Shaping 2026
The pharmacy services sector saw substantial M&A activity between June 2025 and May 2026, as private equity firms continued to
Read More
March 11, 2026
From Policy to Profit: The Biggest Takeaways from Healthcare’s Q4 2025 Earnings Season
As Q4 2025 earnings season wraps up, VMG Health observed some key themes from the publicly traded payers’ and hospital
Read More
March 10, 2026
Scaling DSOs: Why Integration & Liquidity Planning Matter Now
Dental service organizations are no longer an emerging model: They are a permanent and expanding part of the dental landscape.
Read More
March 9, 2026
Healthcare M&A: 2025 Trends and 2026 Outlook
Drawing on findings from VMG Health’s 2026 Healthcare M&A Report, this webinar will highlight how buyers and operators are adapting
Read More
March 2, 2026
2026 Healthcare M&A Report
Your Annual M&A Strategy Starts Here: VMG Health’s 2026 Healthcare M&A Report The 2025 healthcare M&A market reflected the impact
Read More
February 12, 2026
Why Quality of Revenue Matters More Than EBITDA in DSO Strategy
EBITDA Is Only the Beginning In dental service organizations (DSOs), EBITDA often dominates conversations about growth, performance, and valuation, but
Read MoreFinancial Due Diligence Frequently Asked Questions
Frequently Asked Questions
Why do we need healthcare-specific financial due diligence?
Unlike generalist accounting conglomerates that split their attention across multiple sectors, VMG Health has focused exclusively on the healthcare industry for over three decades. Our advisors understand the unique nuances of due diligence in this industry, including reimbursement mechanisms and regulatory risks. This depth of specialized knowledge ensures we uncover hidden liabilities that a generalist firm might miss.
What does a QoE analysis actually reveal?
Our Quality of Earnings healthcare analysis evaluates underlying run-rate earnings, scrutinizes cash-to-accrual conversions, and validates the true sustainability of historical revenue. This process exposes overstated earnings or unsustainable cost structures, empowering you to negotiate from a position of strength.
Can you support both the buy-side and the sell-side?
Yes. We provide independent, healthcare-exclusive advisory services for both buyers mitigating acquisition risk and sellers preparing their assets for a strategic, maximized exit.
Protect Your Healthcare Transaction with Unbiased M&A Due Diligence
Partner with VMG Health to secure the data-driven intelligence you need to expose vulnerabilities, negotiate effectively, and safeguard your enterprise value.
Speak to an Expert